Please login to the form below

sarcoma

This page shows the latest sarcoma news and features for those working in and with pharma, biotech and healthcare.

The candidate just hit its primary endpoint in a Phase II/III trial in soft tissue sarcoma (STS).

AstraZeneca expands alliance with Bicycle Therapeutics

The peptide portion of BT1718 binds to MT1-MMP, which is highly expressed in many solid tumours, including triple negative breast cancer, sarcoma and non-small cell lung cancer, and is
Merck forges closer ties with Cancer Research UK

notable pipeline failures, including evofosfamide for advanced soft tissue sarcoma and pancreatic cancer.
Bayer gets clinical data to support $1.5bn Loxo deal

uncontrolled cellular growth that is evident in a wide range of tumours, including infantile fibrosarcoma, thyroid cancer and various soft tissue sarcomas, but collectively account for less than 1% of all
Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

They are seen in a collection of malignancies including colorectal adenocarcinoma, soft tissue sarcoma, infantile fibrosarcoma and cholangiocarcinoma.
Avelumab costs peg back profit at Merck KGaA

sarcoma and pancreatic cancer after phase III study failures.

More from news
Approximately 6 fully matching, plus 49 partially matching documents found.

Europe vs the US: New drug product approvals

Among the noteworthy approvals are Lartruvo (for the treatment of soft tissue sarcoma, approved in the EU and US), Rubraca (for the treatment of ovarian cancer, only approved in the US),
Case study: Treatment guidance

The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’ s annual conference.
Case study: Treatment guidance

The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’ s annual conference.
Pharma deals during February 2014

for advanced sarcoma.
Interview: Harvey Berger and Timothy Clackson, Ariad

And that was absolutely correct.”. After selling off investigational sarcoma treatment ridaforolimus to Merck &Co following an aborted collaboration attempt, ponatinib emerged as the front-runner in the company's pipeline

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Director development role to Business Director, H...: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Add my company

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...